WOONSOCKET, R.I., Oct. 3, 2019 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation's common stock. The dividend is payable on November 4, 2019, to holders of

WAKEFIELD, Mass., Oct. 3, 2019 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced that on Friday, September 27, 2019 Executive Chairman Boris Jordan purchased 100,000 sha

DALLAS and SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), healthcare's leader and innovator in workforce solutions and staffing services, has scheduled a conference call to discuss its third quarter 2019 financial results on Thursday, October 31, 2019 at

RARITAN, N.J., Oct. 3, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for niraparib, an orally-administered poly ADP-ribose polymerase (PARP) inhibitor, for the treatment of patients with BRCA1/2 gene-mutated metastatic ca

FRANKLIN LAKES, N.J., Oct. 3, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2019 earnings conference call on Tuesday, November 5, 2019, at 8:00 a.m. (ET). BD will issue a press release

IRVINE, Calif., Oct. 3, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) is scheduled to report its third quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, October 30, 2019.  HCP will host a conference call and webcast on Thursday, October 31, 2019, at

NEW YORK CITY, Oct. 3, 2019 /PRNewswire/ -- The American Psychiatric Association recognized the state of Minnesota as a national leader in increasing access to psychiatric health care. The Psychiatric Assistance Line (PAL) was created in 2014 through a grant from the Minnesota Department of Human Services to create better access to mental

SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, today announced updated data from the ongoing Phase 1b study of investigational ME-401, a selective oral inhibitor of PI3K delta. These new data will be presented at MEI's

SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. ("Heron") (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that it intends to offer and sell shares of its common stock in an underwritten regi

WHITE PLAINS, N.Y., Oct. 3, 2019 /PRNewswire/ -- Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a privately held, clinical stage, biopharmaceutical company developing new antibiotics for difficult-to-treat bacterial infections, announced today that its novel lead antibiotic candidate, ACX-362E, for the treatment of CDI was featured in three presentations at